Multiple Surgeries Tied to Worsening Brain Health
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 9, 2024 -- Surgeries are generally safe but cumulatively are associated with cognitive decline and neurodegeneration, according to a study published in the September issue of The Lancet Healthy Longevity.
Jennifer Taylor, Ph.D., from the University of Sydney, and colleagues assessed whether major surgical and medical hospital admissions are associated with cognitive decline in older people (aged 40 to 69 years at recruitment). The analysis included 492,802 participants in the U.K. Biobank, of whom 46,706 underwent magnetic resonance imaging.
The researchers found small, adverse associations with cognition per surgery in fully adjusted models: Reaction time increased by 0.273 ms, fluid intelligence score decreased by 0.057 correct responses, prospective memory (scored as correct at first attempt) decreased (odds ratio, 0.96), and numeric memory maximum correct matches decreased by 0.025. There were also associations between surgeries and smaller hippocampal volume (β = −5.76 mm3) and greater white matter hyperintensities volume (β = 100.02 mm3) in fully adjusted models. Neurodegeneration of the insula and superior temporal cortex were associated with surgeries.
"This is a reminder to medical professionals to consider all treatment options and be cautious in recommending major surgery for older and more vulnerable patients," Taylor said in a statement. "Nonetheless, careful attention in perioperative care is required to prioritize brain health and recovery."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.